Erasmus MC and Politecnico di Milano, together with Spatium Medical and IDE Group, have established a public-private partnership to develop a turbine-based insufflator that improves surgical performance and outcomes by improving ventilation, personalizing insufflation pressure, and efficiently removing smoke created by electrosurgery.
Minimal access surgery is a growing field, with more than 10 million procedures performed globally each year. However, current insufflation devices can cause postoperative pain, difficult management of mechanical ventilation during anaesthesia, and prolonged hospital stays. The development of a turbine-based insufflator addresses these challenges and has the potential to reduce overall healthcare costs.
The project aims to develop the turbine-based insufflator by further investigating and developing the features that benefit patients and surgical outcomes the most. This will be done through animal studies and in-vitro models, leading to the development of a clinical prototype to test safety and efficacy in the first trial in humans. Additionally, an advanced biomechanical in-vitro model will be developed to design, build, and test the system for removing fumes. This model could reduce the need for preclinical studies.
The deliverables of the project include a clinical prototype of the turbine-based insufflator and an advanced biomechanical in-vitro model. If the project is finished, the expected result is a dataset that can help design a turbine-based insufflator that improves surgical performance and outcomes, reduces postoperative pain, shortens hospital stays, and reduces overall healthcare costs.